Savient Pharms Drug Patent Portfolio

Savient Pharms owns 1 orange book drug protected by 5 US patents Given below is the list of Savient Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5872147 Use of oxandrolone in the treatment of chronic obstructive pulmonary disease 05 Dec, 2017 Expired
US6576659 Use of oxandrolone in the treatment of burns an other wounds 05 Dec, 2017 Expired
US6828313 Use of oxandrolone in the treatment of burns and other wounds 05 Dec, 2017 Expired
US6090799 Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 18 Jul, 2017 Expired
US6670351 Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 20 Oct, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Savient Pharms.

Activity Date Patent Number
Patent litigations
Correspondence Address Change 23 Dec, 2008 US6828313
Recordation of Patent Grant Mailed 07 Dec, 2004 US6828313
Patent Issue Date Used in PTA Calculation 07 Dec, 2004 US6828313
Issue Notification Mailed 18 Nov, 2004 US6828313
Dispatch to FDC 27 Oct, 2004 US6828313
Issue Fee Payment Received 19 Oct, 2004 US6828313
Issue Fee Payment Verified 19 Oct, 2004 US6828313
Reverse Issue Fee 19 Oct, 2004 US6828313
Mail Notice of Allowance 18 Oct, 2004 US6828313
Notice of Allowance Data Verification Completed 15 Oct, 2004 US6828313
Case Docketed to Examiner in GAU 01 Oct, 2004 US6828313
Date Forwarded to Examiner 30 Aug, 2004 US6828313
Workflow incoming amendment IFW 19 Aug, 2004 US6828313
Response after Non-Final Action 19 Aug, 2004 US6828313
Information Disclosure Statement (IDS) Filed 19 Aug, 2004 US6828313


Savient Pharms's Family Patents


Family Patents



Savient Pharms Drug List

Given below is the complete list of Savient Pharms's drugs and the patents protecting them.


1. Oxandrin

Oxandrin is protected by 5 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5872147 Use of oxandrolone in the treatment of chronic obstructive pulmonary disease 05 Dec, 2017
(7 years ago)
Expired
US6576659 Use of oxandrolone in the treatment of burns an other wounds 05 Dec, 2017
(7 years ago)
Expired
US6828313 Use of oxandrolone in the treatment of burns and other wounds 05 Dec, 2017
(7 years ago)
Expired
US6090799 Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 18 Jul, 2017
(7 years ago)
Expired
US6670351 Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 20 Oct, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oxandrin's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List